Liver Diseases Therapeutics Market - Global Industry Analysis, Size, Share, Trends and Forecast 2012 - 2018

Submitted by: Submitted by

Views: 51

Words: 2355

Pages: 10

Category: Business and Industry

Date Submitted: 09/24/2014 11:11 PM

Report This Essay

Transparency Market Research

Liver Diseases Therapeutics Market Global Industry Analysis, Size, Share, Trends And Forecast 2012 – 2018

Published Date 16-Jan-2013 Single User License:

USD 4595

Multi User License:

USD 7595

Corporate User License:

USD 10595

112 Page Report

Buy Now

Request Sample

Press Release

Liver Diseases Therapeutics Market is Expected to Reach USD 10.9 Billion Globally in 2018: Transparency Market Research

Transparency Market Research State Tower, 90, State Street, Suite 700. Albany, NY 12207 United States www.transparencymarketresearch.com sales@transparencymarketresearch.com

Liver Diseases Therapeutics Market

REPORT DESCRIPTION

According to the latest market report published by Transparency Market Research "Liver Diseases Therapeutics Market (Chemotherapy, Anti-Virals, Vaccines, Targeted Therapy and Immunosuppressants) Global Industry Analysis, Size, Share, Trends and Forecast, 2012 - 2018", the global liver diseases therapeutics market was worth USD 6.5 billion in 2011 and is expected to reach USD 10.9 billion in 2018, growing at a CAGR of 8.6% from 2012 to 2018. In the overall global market, anti-viral drugs are expected to create its lead position in terms of revenue generation by 2018. Anti-viral drugs will have a share of 32.7% of the global market followed by vaccines at 19.1% in 2018. Browse the Liver Diseases Therapeutics Market full report at http://www.transparencymarketresearch.com/liver-diseases-therapeutics.html The major drivers of the global liver disease therapeutics market are increasing aging population inducing chronic diseases such as hepatitis and liver cancer, increasing global prevalence of liver disorder, high unmet needs existing in liver cancer and increased vaccination in emerging economies. However sideeffects and risks associated with the medication, strict FDA approval norms and other government regulations and availability of alternate treatment procedures may act as the...